摘要
目的为观察重组人表皮生长因子(rhEGF)在感染创面植皮的临床应用。方法选择12例不同损伤原因的创面,创面分泌物培养证实为感染创面,观察创面愈合时间。结果创面植皮全部存活,创面愈合时间短。结论rhEGF对感染创面植皮是安全的、有效的。
Objective To observe the clinical efficacy of recombinent human epidermal growth factor in treatment of the influence surface of the wound after dermatoplasty. Methods The patients suffering from different ,Dressing changed once each day. The dynamic healing rate in different time and healing time were observed. Results There was no obvious adverse reaction.the heal time of wound surface deficient. Conclusions Recombinent human epidermal growth factor can promote the influence surface of the wound after dermatoplasty.
出处
《遵义医学院学报》
2009年第6期573-574,共2页
Journal of Zunyi Medical University
关键词
重组人表皮生长因子
感染
疗效
recombinent human epidermal growth factor
influence
wound healing